Second, certain PSEN1 and PSEN2 mutations associated with FAD have been demonstrated to strongly attenuate the cellular response to GSM treatment in vitro and in a transgenic mouse model of AD [35, 70, 108]. The gene discussed is PSEN1; the disease is Alzheimer disease.